Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.735
-0.085 (-1.76%)
At close: Nov 20, 2024, 4:00 PM
4.730
-0.005 (-0.11%)
After-hours: Nov 20, 2024, 5:49 PM EST
Aquestive Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 432 | 135 | 49 | 156 | 180 | 186 | |
Market Cap Growth | 344.18% | 176.07% | -68.73% | -13.14% | -3.55% | 18.68% | |
Enterprise Value | 391 | 155 | 85 | 169 | 229 | 225 | |
Last Close Price | 4.74 | 2.02 | 0.90 | 3.89 | 5.35 | 5.82 | |
PS Ratio | 6.49 | 2.67 | 1.02 | 3.07 | 3.92 | 3.54 | |
PB Ratio | -9.98 | -1.27 | -0.41 | -1.90 | -3.71 | -30.46 | |
EV/Sales Ratio | 6.63 | 3.06 | 1.79 | 3.32 | 4.99 | 4.28 | |
Debt / Equity Ratio | -0.81 | -0.31 | -0.48 | -0.69 | -0.83 | -9.86 | |
Asset Turnover | 0.70 | 0.88 | 0.80 | 0.81 | 0.65 | 0.64 | |
Inventory Turnover | 2.56 | 3.32 | 3.95 | 4.61 | 4.87 | 4.91 | |
Quick Ratio | 5.78 | 1.77 | 0.81 | 1.83 | 1.84 | 3.37 | |
Current Ratio | 6.37 | 2.24 | 1.01 | 2.15 | 2.11 | 3.68 | |
Return on Equity (ROE) | - | - | - | - | - | -3347.45% | |
Return on Assets (ROA) | -15.57% | -16.49% | -44.16% | -34.71% | -37.93% | -39.82% | |
Return on Capital (ROIC) | - | - | - | - | -116.06% | -59.05% | |
Earnings Yield | -8.15% | -5.84% | -111.37% | -45.15% | -31.01% | -35.52% | |
FCF Yield | -7.96% | -5.47% | -22.19% | -21.69% | -25.56% | -32.64% | |
Buyback Yield / Dilution | -39.07% | -25.69% | -27.99% | -13.15% | -32.71% | -22.34% | |
Total Shareholder Return | -39.07% | -25.69% | -27.99% | -13.15% | -32.71% | -22.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.